Galmed Pharmaceuticals Ltd.

(GLMD) Trade

By |

Profile

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Contact Information

Website: www.galmedpharma.com
Email: info@galmedpharma.com
Main Phone: +972 36938448
Address: 16 Tiomkin Street
City / Town: Tel Aviv
Country: ISR
Postal Code: 6578317

Issuer Information

Exchange: NSC
CEO: Allen Baharaff
Employees: 17
NAICS: Pharmaceutical P
$ 8.66 $ -0.73 (-7.77%)
Last Price 8.66 Change $ -0.73 Change % -7.77 Tick N/A
Bid 7.00 Bid Size 1,500.00 Ask 9.50 Ask Size 100.00
Open 9.35 High 9.50 Low 8.36 Prev Close 9.39
Last Trade Volume 141,759 52 Wk Hi 27.06 52 Wk Low 3.61
Market Cap 181.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,003,828.00 EPS (TTM) -0.66 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 32 32 32 43
Low Target Price Estimate 14 14 14 30
Mean Target Price Estimate 20.8 20.8 20.8 33.2
Standard Deviation 7.4 7.4 7.4 5.54
Date of Most Recent Estimate 05/23/18 05/23/18 05/23/18 06/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1.4